Literature DB >> 12110824

Maternal vaginal microflora during pregnancy and the risk of asthma hospitalization and use of antiasthma medication in early childhood.

Christine Stabell Benn1, Poul Thorsen, Jørgen Skov Jensen, Birgitte Boysen Kjaer, Hans Bisgaard, Morten Andersen, Klaus Rostgaard, Bengt Björkstén, Mads Melbye.   

Abstract

BACKGROUND: Infants with wheezing and allergic diseases have a microflora that differs from that of healthy infants. The fetus acquires microorganisms during birth when exposed to the maternal vaginal microflora. It is therefore conceivable that the maternal vaginal microflora might influence the establishment of the infant flora and, as a consequence, the development of wheezing and allergic diseases.
OBJECTIVE: We sought to study the associations between the composition of the maternal vaginal microflora and the development of wheezing and asthma in childhood.
METHODS: We performed a population-based cohort study in Denmark. Vaginal samples for bacterial analysis were obtained during pregnancy. A total of 2927 women (80% of the invited women) completed the study and had 3003 live infants. Infant wheezing was assessed as one or more hospitalizations for asthma between 0 and 3 years of age. Asthma was assessed as use of 3 or more packages of antiasthma medication between 4 and 5 years of age.
RESULTS: Maternal vaginal colonization with Ureaplasma urealyticum during pregnancy was associated with infant wheezing (odds ratio [OR], 2.0; 95% CI, 1.2-3.6), but not with asthma, during the fifth year of life. Maternal colonization with staphylococci (OR, 2.2; 95% CI, 1.4-3.4) and use of antibiotics in pregnancy (OR, 1.7; 95% CI, 1.1-2.6) were associated with asthma during the fifth year of life.
CONCLUSION: The composition of the maternal vaginal micro-flora might be associated with wheezing and asthma in the offspring up to 5 years of age.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110824     DOI: 10.1067/mai.2002.125833

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  28 in total

Review 1.  How stress induces intestinal hypersensitivity.

Authors:  Andre G Buret
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

Review 2.  Asthma: epidemiology, etiology and risk factors.

Authors:  Padmaja Subbarao; Piush J Mandhane; Malcolm R Sears
Journal:  CMAJ       Date:  2009-09-14       Impact factor: 8.262

Review 3.  Influence of maternal microbiota during pregnancy on infant immunity.

Authors:  D D Nyangahu; H B Jaspan
Journal:  Clin Exp Immunol       Date:  2019-06-21       Impact factor: 4.330

4.  The EPIIC hypothesis: intrapartum effects on the neonatal epigenome and consequent health outcomes.

Authors:  H G Dahlen; H P Kennedy; C M Anderson; A F Bell; A Clark; M Foureur; J E Ohm; A M Shearman; J Y Taylor; M L Wright; S Downe
Journal:  Med Hypotheses       Date:  2013-02-12       Impact factor: 1.538

Review 5.  Ureaplasma species: role in diseases of prematurity.

Authors:  Rose M Viscardi
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 6.  Potential uses of probiotics in clinical practice.

Authors:  Gregor Reid; Jana Jass; M Tom Sebulsky; John K McCormick
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

7.  Maternal intestinal flora and wheeze in early childhood.

Authors:  N E Lange; J C Celedón; E Forno; N P Ly; A Onderdonk; L Bry; M L Delaney; A M DuBois; D R Gold; S T Weiss; A A Litonjua
Journal:  Clin Exp Allergy       Date:  2012-06       Impact factor: 5.018

Review 8.  Effects of intestinal microflora and the environment on the development of asthma and allergy.

Authors:  Bengt Björkstén
Journal:  Springer Semin Immunopathol       Date:  2003-10-24

Review 9.  Stress and food allergy: mechanistic considerations.

Authors:  Hannah M C Schreier; Rosalind J Wright
Journal:  Ann Allergy Asthma Immunol       Date:  2013-08-28       Impact factor: 6.347

Review 10.  Ureaplasma species: role in neonatal morbidities and outcomes.

Authors:  Rose Marie Viscardi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2013-08-19       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.